Related Experiment Video
Updated: Aug 18, 2026

11:31
Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa
Published on: June 30, 2016
Exploiting Pseudomonas putida for drug development
1Albert-Ludwigs-Universität Freiburg im Breisgau, Institut für Pharmazeutische Biologie und Biotechnologie, Freiburg, Germany.
Chemistry & Biology
|March 31, 2005
Abstract:
In this issue of Chemistry & Biology, a strategy that combines large DNA fragment recombineering in Escherichia coli and heterologous expression in Pseudomonas putida is described. The work focuses on myxochromide S, a natural compound produced by Stigmatella aurantiaca.
